UPLC-LTQ-Orbitrap Study on Rat Urinary Metabolites of 5-Methoxy-Alpha-Methyltryptamine

Zhutao Guo,Keran Ding,Shuiqing Zheng,Chunfang Ni,Siyang He,Qianya Deng,Chen Liang
DOI: https://doi.org/10.2174/0113892002295551240628061732
2024-07-12
Current Drug Metabolism
Abstract:Objective: 5-Methoxy-α-Methyltryptamine (5-MeO-AMT) is a new psychoactive substance which is abused due to its hallucinogenic and euphoric effects. This study aimed to study the metabolic characteristics of 5-MeO-AMT. Methods: Five rats were given intraperitoneal injection at a dose of 50 mg/kg of 5-MeO-AMT, and their urine was subsequently collected at different times within 7 days. Ultra-high performance liquid chromatography-- tandem high-resolution mass spectrometry (UPLC-LTQ-Orbitrap) was used to detect the precise molecular weight and fragment ions of 5-MeO-AMT and its possible metabolites in the urine sample extracted with benzene-ethyl acetate. Results: Three metabolites, including OH-5-MeO-AMT, α-Me-5-HT, and N-Acetyl-5-MeO-AMT were identified in rats’ urine. The major metabolic pathways involved O-demethylation, hydroxylation of indole ring, and Acetylation on aliphatic amines. Conclusion: The results of this study are an important reference for the identification and screening of toxicants of 5-MeO-AMT.
pharmacology & pharmacy,biochemistry & molecular biology
What problem does this paper attempt to address?